Defence Therapeutics Inc.
Research Defence Therapeutics Inc. (DTC) on Bullrun: market cap EUR 17.43M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerDTC
- ExchangeF
- CountryCanada
- SectorHealthcare
- IndustryBiotechnology
- CurrencyEUR
- Market capEUR 17.43M
- Financial periodQ4 2025
- Net income-EUR 1.52M
- Free cash flow-EUR 1.39M
Valuation Snapshot
latest market cap is EUR 17.43M.
About Defence Therapeutics Inc.
Defence Therapeutics Inc. develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases. The company focuses on the research, development, and advancement of products using its Accum technology, including antibody drug conjugates targeting various cancers;
Frequently asked questions
What is Defence Therapeutics Inc.'s market cap?
Defence Therapeutics Inc.'s market capitalization is EUR 17.43M.
What does Defence Therapeutics Inc. do?
Defence Therapeutics Inc. develops a biological drug enhancer platform that improves the efficacy and safety of a multitude of a multitude of biological/biosimilar-based pharmaceuticals used in the treatment of cancer and infectious diseases.